 |
| Image: moneycontrol.com |
Various reports that fresh investigations are underway into the way GlaxoSmithKline failed to disclose the Company's true operating condition to participants and beneficiaries of the plans (including disclosures relating disclosures relating to the safety of Avandia) are hitting the internet today.
A Market Watch press release writes:
If you are a current or former participant in GlaxoSmithKline 401(k) plan and have questions concerning your legal rights, you are encouraged to contact Holzer Holzer & Fistel, LLC and its attorneys Michael I. Fistel Jr., Esq. or Marshall P. Dees, Esq. via email at mfistel@holzerlaw.com, or mdees@holzerlaw.com, or via toll-free telephone at (888) 508-6832.
More about the Employee Retirement Income Security Act of 1974 HERE
More information if and when it filters through.
Fid
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING
1 comment: